Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:32 PM
Ignite Modification Date:
2025-12-24 @ 5:32 PM
NCT ID:
NCT00162968
Eligibility Criteria:
Inclusion Criteria:
* median total pain score at baseline week \>=4 on a 10 point numerical rating scale
* characteristic symptoms of polyneuropathy within at least 6 months
* diagnosis confirmed by physical examination, neurophysiologic exam. and/or quantitative sensory testing
* pain at least 4 of 7 days
* fertile women are using anticonceptive
Exclusion Criteria:
* other cause to pain than polyneuropathy
* former allergic reactions on escitalopram
* known adverse events on escitalopram
* pregnancy or nursing
* critical disease (terminal cancer, cardial incompensation or critical renal or lung disease)
* treatment with monoamine oxidase inhibitors between the trial or 2 weeks before or after treatment with other antidepressants, antiepileptic agents or opioids
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
80 Years
Study:
NCT00162968
Study Brief:
Protocol Section:
NCT00162968